Licensing life-saving drugs for developing countries: evidence from the medicines patent pool

Alberto Galasso and Mark Schankerman

LSE Research Online Documents on Economics from London School of Economics and Political Science, LSE Library

Abstract: We study the effects of the Medicines Patent Pool (MPP)—an institution that pools patents across geographical markets—on the licensing and adoption of life-saving drugs in low- and middle-income countries. We show the presence of an immediate and large increase in licensing when a patent is included in the MPP. We also show evidence that the pool increases actual entry and volume of sales, but these impacts are much smaller than on licensing, which is due to the geographic bundling of licenses. The paper highlights the potential of pools in promoting diffusion of biomedical innovation in developing countries.

Keywords: patents; licensing; patent pool; pharmaceuticals; HIV; public health; developing countries (search for similar items in EconPapers)
JEL-codes: I18 O31 O34 (search for similar items in EconPapers)
Pages: 13 pages
Date: 2024-11-30
New Economics Papers: this item is included in nep-ino and nep-ipr
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in The Review of Economics and Statistics, 30, November, 2024, 106(6), pp. 1529 – 1541. ISSN: 0034-6535

Downloads: (external link)
http://eprints.lse.ac.uk/123932/ Open access version. (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ehl:lserod:123932

Access Statistics for this paper

More papers in LSE Research Online Documents on Economics from London School of Economics and Political Science, LSE Library LSE Library Portugal Street London, WC2A 2HD, U.K.. Contact information at EDIRC.
Bibliographic data for series maintained by LSERO Manager ().